475 related articles for article (PubMed ID: 26121266)
1. Emergence of Ciprofloxacin-Resistant Salmonella enterica Serovar Typhi in Italy.
García-Fernández A; Gallina S; Owczarek S; Dionisi AM; Benedetti I; Decastelli L; Luzzi I
PLoS One; 2015; 10(6):e0132065. PubMed ID: 26121266
[TBL] [Abstract][Full Text] [Related]
2. First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan.
Lee CJ; Su LH; Huang YC; Chiu CH
J Microbiol Immunol Infect; 2013 Dec; 46(6):469-73. PubMed ID: 23465712
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin.
Misra R; Thakare R; Amrin N; Prasad KN; Chopra S; Dhole TN
Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):472-9. PubMed ID: 27618918
[TBL] [Abstract][Full Text] [Related]
5. Emergence and properties of fluoroquinolone resistant Salmonella enterica serovar Typhi strains isolated from Nepal in 2002 and 2003.
Nobthai P; Serichantalergs O; Wongstitwilairoong B; Srijan A; Bodhidatta L; Malla S; Mason CJ
Southeast Asian J Trop Med Public Health; 2010 Nov; 41(6):1416-22. PubMed ID: 21329318
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009.
Menezes GA; Harish BN; Khan MA; Goessens WH; Hays JP
Clin Microbiol Infect; 2012 Mar; 18(3):239-45. PubMed ID: 21714829
[TBL] [Abstract][Full Text] [Related]
7. Hotspots sequences of gyrA, gyrB, parC, and parE genes encoded for fluoroquinolones resistance from local Salmonella Typhi strains in Jakarta.
Nathania I; Nainggolan IM; Yasmon A; Nusatia ACM; Tjoa E; Gunardi WD; Moehario LH
BMC Microbiol; 2022 Oct; 22(1):250. PubMed ID: 36253712
[TBL] [Abstract][Full Text] [Related]
8. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
[TBL] [Abstract][Full Text] [Related]
9. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait.
Dimitrov T; Dashti AA; Albaksami O; Jadaon MM
J Clin Pathol; 2010 Jan; 63(1):83-7. PubMed ID: 19889623
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of travel-related Salmonella enterica serovar Typhi isolates detected in Switzerland (2002-2013) and molecular characterization of quinolone resistant isolates.
Nüesch-Inderbinen M; Abgottspon H; Sägesser G; Cernela N; Stephan R
BMC Infect Dis; 2015 May; 15():212. PubMed ID: 25963025
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic susceptibility pattern and the indicator of decreased ciprofloxacin susceptibility of Salmonella enterica serovar Typhi isolated from Dhulikhel Hospital, Nepal.
Acharya D; Trakulsomboon S; Madhup SK; Korbsrisate S
Jpn J Infect Dis; 2012; 65(3):264-7. PubMed ID: 22627312
[TBL] [Abstract][Full Text] [Related]
12. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
Turner AK; Nair S; Wain J
J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
[TBL] [Abstract][Full Text] [Related]
13. Ciprofloxacin-resistant Salmonella enterica serovar typhi from Kuwait with novel mutations in gyrA and parC genes.
Dimitrov T; Dashti AA; Albaksami O; Udo EE; Jadaon MM; Albert MJ
J Clin Microbiol; 2009 Jan; 47(1):208-11. PubMed ID: 18971360
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics in adult patients with Salmonella bacteremia and analysis of ciprofloxacin-nonsusceptible isolates.
Cheng MW; Lee CM; Wang NY; Wu AY; Lin CC; Weng LC; Liu CP; Shih SC
J Microbiol Immunol Infect; 2015 Dec; 48(6):692-8. PubMed ID: 26542649
[TBL] [Abstract][Full Text] [Related]
15. Validation of Pefloxacin for detection of fluoroquinolone (FQ) resistance among
Inayath SB; Broor S; Gupta R; Agarwal P; Majumder S; Anveshi AK; Gaind R
J Med Microbiol; 2021 Aug; 70(8):. PubMed ID: 34356003
[No Abstract] [Full Text] [Related]
16. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.
Hassing RJ; Menezes GA; van Pelt W; Petit PL; van Genderen PJ; Goessens WH
Int J Antimicrob Agents; 2011 Mar; 37(3):240-3. PubMed ID: 21227657
[TBL] [Abstract][Full Text] [Related]
17. Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A.
Renuka K; Kapil A; Kabra SK; Wig N; Das BK; Prasad VV; Chaudhry R; Seth P
Microb Drug Resist; 2004; 10(2):146-53. PubMed ID: 15256030
[TBL] [Abstract][Full Text] [Related]
18. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003.
Shirakawa T; Acharya B; Kinoshita S; Kumagai S; Gotoh A; Kawabata M
Diagn Microbiol Infect Dis; 2006 Apr; 54(4):299-303. PubMed ID: 16466897
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance and molecular subtypes of Salmonella enterica serovar Typhi isolates from Kolkata, India over a 15 years period 1998-2012.
Das S; Samajpati S; Ray U; Roy I; Dutta S
Int J Med Microbiol; 2017 Jan; 307(1):28-36. PubMed ID: 27916384
[TBL] [Abstract][Full Text] [Related]
20. A Multicountry Molecular Analysis of Salmonella enterica Serovar Typhi With Reduced Susceptibility to Ciprofloxacin in Sub-Saharan Africa.
Al-Emran HM; Eibach D; Krumkamp R; Ali M; Baker S; Biggs HM; Bjerregaard-Andersen M; Breiman RF; Clemens JD; Crump JA; Cruz Espinoza LM; Deerin J; Dekker DM; Gassama Sow A; Hertz JT; Im J; Ibrango S; von Kalckreuth V; Kabore LP; Konings F; Løfberg SV; Meyer CG; Mintz ED; Montgomery JM; Olack B; Pak GD; Panzner U; Park SE; Razafindrabe JL; Rabezanahary H; Rakotondrainiarivelo JP; Rakotozandrindrainy R; Raminosoa TM; Schütt-Gerowitt H; Sampo E; Soura AB; Tall A; Warren M; Wierzba TF; May J; Marks F
Clin Infect Dis; 2016 Mar; 62 Suppl 1(Suppl 1):S42-6. PubMed ID: 26933020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
